Literature DB >> 12023923

Cluster of African trypanosomiasis in travelers to Tanzanian national parks.

Tomas Jelinek1, Zeno Bisoffi, Lucio Bonazzi, Pieter van Thiel, Ulf Bronner, Albie de Frey, Svein Gunnar Gundersen, Paul McWhinney, Diego Ripamonti.   

Abstract

Game parks in Tanzania have long been considered to be at low risk for African trypanosomiasis; however, nine cases of the disease associated with these parks were recently reported. The outbreak was detected through TropNetEurop, a sentinel surveillance network of clinical sites throughout Europe.

Entities:  

Mesh:

Year:  2002        PMID: 12023923      PMCID: PMC2738477          DOI: 10.3201/eid0806.010432

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


African trypanosomiasis (sleeping sickness), a serious infection caused by a protozoan (Trypanosoma brucei), is usually spread to humans by the tsetse fly via infected animals and humans. Although the World Health Organization has reported a dramatic increase in incidence in Africa, the disease has remained a rare but well-documented cause of fever in travelers returning from endemic areas. In recent years, infection in returning travelers has been more likely to be due to the East African form (caused by T. brucei rhodesiense), rather than the West African form (which is due to T. brucei gambiense); the latter form causes a fulminant illness for which rapid diagnosis is necessary (,). We report details of nine recent cases caused by the West African form of this disease, one fatal; all of the cases occurred in travelers to Tanzanian national parks.

Case Reports

Game parks in Tanzania have long been considered to be low-risk areas for African trypanosomiasis (. However, in February 2001, two index patients and seven additional European and South African patients were seen with trypanosomiasis acquired in the Tarangire and Serengeti National Parks, Tanzania (. The patients were identified and reported in TropNetEurop, a sentinel surveillance network of clinical sites throughout Europe for monitoring imported infectious diseases. All of the South African patients but one were European nationals (Table). To our knowledge, all patients had traveled to the Tarangire and Serengeti National Parks, in addition to a number of other destinations. This area in East Africa has been implicated as being endemic for African trypanosomiasis. However, the case incidence in Tanzanian and foreign nationals has been very low in recent decades.
Table

Patients with African trypanosomiasis, Tanzania

No.SexAgeNationalityMo/yr of
diagnosisClinical details and treatmentTravel historya
1M33Italian02/01Skin lesion (back), fever, nausea/vomiting; no major complications; treatment with suraminTourist: Kenya; Lake Manyara, Serengeti, and Ngorongoro NPs
2M32Italian02/01Skin lesion left leg; fever; multiorgan failure; anuria; treatment with pentamidineTourist: East Tsavo, Ngorongoro, and Serengeti NPs
3F44British02/01Skin lesion left leg; fever; no major complications; treatment with suraminTourist: Nairobi, Amboseli, Lake Manyara, Ngorongoro, and Serengeti NPs
4M41Swedish03/01Skin lesion right foot; fever; treatment with suraminTourist: Lake Manyara, Ngorongoro, Tarangire, and Serengeti NPs
5M68South African03/01Fever; renal failure; acidosis; jaundice; DIC; treatment with melasoprolTourist: Serengeti NP
6F27Norwegian03/01Skin lesion left side of face; fever; no complications; treatment with suraminResearch project on zebras: Ngorongoro and Serengeti NPs
7M60Dutch03/01Fever; treatment with suraminTarangire NP
8F55Dutch04/01Skin lesion left ankle; fever; headache; treatment with suraminTarangire NP
9F53Dutch06/01Skin lesion right leg; fever; headache; intracerebral manifestation; coma; death; treatment with suramin and melasoprolLake Manyara, Ngorongo, and Serengeti NPs

aEast Tsavo NP and Amboseli NP are in Kenya; all other NPs mentioned are in Tanzania.
NP, national park; DIC, disseminated intravascular coagulopathy.

aEast Tsavo NP and Amboseli NP are in Kenya; all other NPs mentioned are in Tanzania.
NP, national park; DIC, disseminated intravascular coagulopathy. During their journey or briefly after their return, the patients, all febrile, were seen by general practitioners or emergency departments. Most patients were seen during the primary stage of disease (patients 1, 3, 4, 6, 7, 8; Table); however, several showed signs of the secondary stage, including cerebral manifestations. Most patients also showed a typical skin lesion, the trypanosome chancre. Diagnosis was established by thin and thick blood film. Although three patients had multiorgan failure, and specific medication was difficult to obtain, drug treatment proved successful in all but one patient, who died. Drugs for treatment were not chosen for the clinical stage the patients exhibited but rather for availability. Thus, patients with complications and a manifest secondary stage of disease received pentamidine only.

Conclusions

The temporal clustering of imported cases suggests a change in the local epidemiology of this disease and may herald further cases in tourists during the current travel season. For 1998, the World Tourism Organization recorded 450,000 visitors to Tanzania (, for a potential annual incidence of trypanosomiasis in tourists to Tanzania of at least 9/450,000. This is an increase from near zero during recent years to 2/100,000. The risk for those visiting the Tarangire and Serengeti National Parks is obviously higher. Reaction of the Tanzanian authorities involved strengthening installation of insecticide-impregnated locations in Serengeti to include roads, lodges, staff quarters, and campsites. This initial program resulted in a dramatic decline of tsetse flies in Serengeti during the second half of 2001. This effort will have to be sustained by mandatory killing of flies at some keys areas including Serengeti, Tarangire, and Lake Manyara National Parks. The National Medical Research Program has been directed to screen more people for the disease around these foci. For many of the patients, drugs for treatment were extremely difficult to obtain. For some European patients, treatment with suramin was possible only after informal help from member sites of the network. Drugs for treatment (suramin, melasoprol, and eflornithin) have now been obtained. Surveillance in cattle to establish their role in the epidemiology of the disease will also be conducted (Tanzania Chief Veterinary Officer, pers. comm.). This report highlights the effectiveness and importance of sentinel surveillance methods for monitoring imported infectious diseases in Europe. TropNetEurop, the network that identified and reported the index cases, is known for its speed of reporting, often within days of diagnosis. The network’s use of member sites as regional referral centers is based on an anonymous reporting system at sentinel clinics. Discussion of the index patients by member sites triggered increased awareness within the network and led to the rapid recording of additional patients and a pattern that might have otherwise gone undetected.
  4 in total

Review 1.  African trypanosomiasis in two travelers from the United States.

Authors:  A Sinha; C Grace; W K Alston; F Westenfeld; J H Maguire
Journal:  Clin Infect Dis       Date:  1999-10       Impact factor: 9.079

2.  Fulminant disease simulating bacterial sepsis with disseminated intravascular coagulation after a trip to East Africa.

Authors:  B M Sanner; C Doberauer; M Tepel; W Zidek
Journal:  Intensive Care Med       Date:  2000-05       Impact factor: 17.440

3.  Trypanosoma brucei rhodesiense infection imported to Mexico from a tourist resort in Kenya.

Authors:  S Ponce-de-León; M Lisker-Melman; M Kato-Maeda; A Gamboa-Domínguez; C Ontiveros; R H Behrens; A González-Ruiz
Journal:  Clin Infect Dis       Date:  1996-10       Impact factor: 9.079

4.  African sleeping sickness in tourists returning from Tanzania: the first 2 Italian cases from a small outbreak among European travelers.

Authors:  Diego Ripamonti; Marco Massari; Claudio Arici; Ermanno Gabbi; Claudio Farina; Maria Brini; Carlo Capatti; Fredy Suter
Journal:  Clin Infect Dis       Date:  2001-11-19       Impact factor: 9.079

  4 in total
  28 in total

1.  Dermatologic Infectious Diseases in International Travelers.

Authors:  Mary E. Wilson; Lin H. Chen
Journal:  Curr Infect Dis Rep       Date:  2004-02       Impact factor: 3.725

Review 2.  Cardiac involvement with parasitic infections.

Authors:  Alicia Hidron; Nicholas Vogenthaler; José I Santos-Preciado; Alfonso J Rodriguez-Morales; Carlos Franco-Paredes; Anis Rassi
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

3.  Arboprotozoae.

Authors: 
Journal:  Transfus Med Hemother       Date:  2009       Impact factor: 3.747

4.  African Trypanosomiasis: Changing Epidemiology and Consequences.

Authors:  Jean-Paul Chretien; Bonnie L Smoak
Journal:  Curr Infect Dis Rep       Date:  2005-01       Impact factor: 3.725

5.  Fever, headache, fatigue and chancre in a traveller returning from Tanzania.

Authors:  Jp Davis; Vp Chaubey; R Warren; M Parkins; M Louie; D Gregson; D Sabuda; S Kuhn
Journal:  Can J Infect Dis Med Microbiol       Date:  2012       Impact factor: 2.471

6.  Trypanosoma spp. in Swedish game animals.

Authors:  Magnus Neumüller; Kenneth Nilsson; Carl Påhlson
Journal:  Parasitol Res       Date:  2011-05-26       Impact factor: 2.289

Review 7.  Options for field diagnosis of human african trypanosomiasis.

Authors:  François Chappuis; Louis Loutan; Pere Simarro; Veerle Lejon; Philippe Büscher
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

Review 8.  Human African trypanosomiasis in endemic populations and travellers.

Authors:  J A Blum; A L Neumayr; C F Hatz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-09-07       Impact factor: 3.267

Review 9.  Revisiting zoonotic human African trypanosomiasis control in Uganda.

Authors:  Sonia Menon; Rodolfo Rossi; Leon Nshimyumukiza; Kate Zinszer
Journal:  J Public Health Policy       Date:  2015-12-03       Impact factor: 2.222

10.  Human African trypanosomiasis in a traveler: diagnostic pitfalls.

Authors:  Eyal Meltzer; Eyal Leshem; Shmuel Steinlauf; Shulamit Michaeli; Yechezkel Sidi; Eli Schwartz
Journal:  Am J Trop Med Hyg       Date:  2012-08       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.